基本信息
views: 91
Career Trajectory
Bio
Date of birth: February 1, 1959
Nationality: Italy
Work address: Institute of Oncology Research (IOR), Via Chiesa 5, 6500 Bellinzona, CH
Email: carlo.catapano@ior.usi.ch
Carlo V. Catapano, M.D., Ph.D. is the Director of the Institute of Oncology Research (IOR), Head of Tumor Biology and Experimental Therapeutics Program, and Group Leader of Experimental Therapeutics at the IOR in Bellinzona, Switzerland.
Dr. Catapano graduated in Medicine at the University of Naples (Naples, IT) in 1983. He completed the residency in Medical Oncology at the University of Naples (Naples, IT) in 1986, and from 1985 to 1988 he was at the Mario Negri Institute for Pharmacological Research (Milan, IT) as post-graduate fellow in cancer pharmacology. From 1988, he was a research fellow in the Department of Biochemistry of the Wake Forest University (WFU) and at the WFU Comprehensive Cancer Center in Winston-Salem, NC, USA. He received the PhD in Biochemistry from WFU in 1993 working on DNA replication mechanisms and their relevance for anticancer drug action. From 1993 to 2003, he was Professor in Departments of Experimental Oncology, Biochemistry and Molecular Biology, and Medicine (Oncology/Hematology) at the Medical University of South Carolina (MUSC) in Charleston, SC, USA. He also had joint appointments as senior member of the Hollings Cancer Center, Center for Molecular and Structural Biology, and Laboratory of Cancer Genomics of the MUSC. From 2003, he is the Director of the Laboratory of Experimental Oncology and then Director of the Institute of Oncology Research (IOR) in Bellinzona, Switzerland. From 2003, he has also been Leader of the Experimental Therapeutics Group and Head of the Tumor Biology and Experimental Therapeutics Program at IOR.
Major areas of expertise in his research team comprise cancer biology, molecular pharmacology, RNA biology, RNA therapeutics, preclinical investigation and early clinical studies of anticancer drugs. The primary focus in his research group is currently the mechanisms of deregulation of transcriptional and epigenetic processes in human cancers and the development of innovative therapeutic strategies. The current efforts aim at understanding the role of intra-tumor heterogeneity and tumor cell plasticity and the specific aspects related to cancer stem cell biology, tumor progression and treatment resistance.
Research Interests
Papers共 229 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
crossref(2023)
crossref(2023)
crossref(2023)
crossref(2023)
crossref(2023)
crossref(2023)
crossref(2023)
crossref(2023)
crossref(2023)
crossref(2023)
Load More
Author Statistics
#Papers: 234
#Citation: 5893
H-Index: 46
G-Index: 72
Sociability: 7
Diversity: 3
Activity: 75
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn